
Phil Newman joins Gali Bloch Liran and Amir Alroy to explore how longevity is becoming an industry: the timing behind building in an emerging market, the distance between scientific progress and a viable business, and what it will take to make healthier years accessible.
Ten years after his startup closed, Phil Newman walked past a trade-show stand displaying the kind of technology his team had been building. The opportunity had been real. His company had arrived before the market was ready.
That experience became part of how he approached longevity. When Amir Alroy and I sat down with Phil, I wanted to understand how a founder learns to recognize an emerging opportunity after experiencing the cost of being too early.
The experience we bring into the next venture
Phil’s earlier company had been connecting equipment through mobile networks before the Internet of Things became a familiar category. The technology worked, but the infrastructure and customer readiness needed to support the business were still developing. The company failed to close its Series A.
His account makes the question of timing very concrete. Founders can see a future clearly and still face a market that needs more time to reach it. Experience shapes the questions they ask on the next attempt: who needs this, what must change for adoption to happen, and how will the business survive until then?
With Longevity.Technology, Phil began by mapping a field that was still taking shape. Publishing, interviewing researchers and following investment became ways to understand where an industry could emerge.
Giving an emerging industry a clearer map
Phil distinguishes between “longevity now” and “longevity next”: the services and approaches available today, and the biotechnology being developed for the future.
That distinction matters when the same word appears on a supplement bottle, a clinic’s website and a drug-development presentation. Each involves different evidence, business models and timelines.
I asked Phil how this growing field becomes more scientifically grounded. His answer brings us to the work behind the headlines: understanding what a company is developing, which condition it aims to address, how it could move through clinical development, and where a commercial pathway might exist.
For founders and investors, that creates a more useful conversation about what is being built and what still needs to happen.
Who will pay for healthier years?
Our conversation also moved toward access. I asked what it would take for longevity care to reach more people, beyond those who can afford expensive services.
Phil described different clinic models and the potential of remote delivery, while Amir pressed him on whether the business models themselves are becoming more sustainable. As we looked further ahead, the question widened to healthcare systems, prevention and who would fund interventions at population scale.
This is where the business discussion connects directly with impact. The promise of healthier years depends on the evidence, the delivery model and the people able to benefit.
Watch or listen to the full episode with Phil Newman and Amir Alroy for a closer look at how scientific ambition, commercial reality and access meet in the longevity economy.
About Phil Newman
Phil Newman is the Founder & CEO of Longevity.Technology. His background spans marketing, business development and leadership roles across emerging technology markets. He founded the platform to cover the science, business and investment activity shaping longevity. the Longevity.technology team and advisory board
Learn more about Phil and Longevity.Technology.
About the Longevity Series
The Human Founder’s Longevity Series, hosted by Gali Bloch Liran together with Amir Alroy, explores the connections between health, entrepreneurship, science and the ability to live and contribute over time.
The series is made possible with Welltech Ventures, HUNTER Executive Search and LeumiTech.
Continue the Conversation
If this conversation resonated with you, we invite you to continue the journey with us:
📩 Join The Human Founder newsletter for deeper reflections, founder stories, and behind-the-scenes insights on leadership, resilience, longevity, and the entrepreneurial journey.
📖 Explore my book, The Human Founder: How to Build a Startup and Stay Alive, where I go deeper into many of the questions at the heart of this conversation: how to sustain ambition over time, navigate the emotional realities of entrepreneurship, and build without losing the human being behind the company.